Obesity and oxidative stress intensify psoriasis through activating IL-17/IL-23 pathway

被引:0
|
作者
Vikasari, Suci Nar [1 ,3 ]
Sukandar, Elin Yulinah [3 ]
Suciati, Tri [2 ]
Adnyana, I. Ketut [2 ]
机构
[1] Inst Teknol Bandung, Sch Pharm, Doctoral Program Pharm, Bandung, Indonesia
[2] Inst Teknol Bandung, Sch Pharm, Bandung, Indonesia
[3] Univ Jenderal Achmad Yani, Fac Pharm, Cimahi, Indonesia
来源
PHYSIOLOGY AND PHARMACOLOGY | 2024年 / 28卷 / 01期
关键词
Psoriasis; Autoimmune; Obese; Oxidative stress; IL-17/IL-23; pathway; PATHOPHYSIOLOGY; PATHOGENESIS; UPDATE;
D O I
10.61186/phypha.28.1.18
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Psoriasis is an autoimmune disease characterized by keratinocyte hyperproliferation and skin thickening. Psoriasis is caused by a complicated interaction between the innate and acquired immune systems. In the skin, this reaction produces abnormal T helper cell (Th1, Th17, and Th23) reactivation. Keratinocyte hyperproliferation is caused by increased cell (TNF-alpha), and interferon-gamma (INF-gamma). Obesity, free fatty acids, microorganisms in the skin and digestive tract, free radicals in the body, and the cardiovascular system are also essential variables in psoriasis. Several variables influence the cytokine activation of the IL17/IL-23 pathway. Obesity, which is marked by changes in lipid profile in psoriasis patients, is linked to increased oxidative stress and the generation of proinflammatory cytokines, both of which can potentially trigger psoriasis relapse. Antioxidant-rich diet and intake can be employed as one of the stages in preventing psoriasis recurrence.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 50 条
  • [22] IL-23 and IL-17 in ankylosing spondylitis
    Daniel Wendling
    Rheumatology International, 2010, 30 : 1547 - 1547
  • [23] IL-23/IL-17 Axis in IBD
    Sarra, Massimiliano
    Pallone, Francesco
    MacDonald, Thomas T.
    Monteleone, Giovanni
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (10) : 1808 - 1813
  • [24] MAPPING THE IL-23/IL-17 AXIS
    Elewaut, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 766 - 766
  • [25] The IL-23/IL-17 axis in inflammation
    Iwakura, Y
    Ishigame, H
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05): : 1218 - 1222
  • [26] IL-19 is a novel component of the pathogenetic IL-23/IL-17 cascade in psoriasis
    Witte, E.
    Kokolakis, G.
    Witte, K.
    Philipp, S.
    Doecke, W.
    Babel, N.
    Wittig, B.
    Warszawska, K.
    Kurek, A.
    Erdmann-Keding, M.
    Kunz, S.
    Asadullah, K.
    Kadin, M.
    Volk, H.
    Sterry, W.
    Wolk, K.
    Sabat, R.
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (03) : E20 - E20
  • [27] Interpreting the Function of the IL-23/IL-17 Axis through Bioinformatics
    Vazquez-Jimenez, Sonia Isela
    Gonzalez-Sanchez, Grecia Denisse
    Guerrero-Velazquez, Celia
    Guzman-Flores, Juan Manuel
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2024,
  • [28] Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors
    Huang, Yu-Huei
    Chang, Lun-Ching
    Chang, Ya-Ching
    Chung, Wen-Hung
    Yang, Shun-Fa
    Su, Shih-Chi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [29] Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data
    Sakkas, Lazaros I.
    Bogdanos, Dimitrios P.
    AUTOIMMUNITY REVIEWS, 2017, 16 (01) : 10 - 15
  • [30] IL-23 is important in IL-17 induction in tuberculosis
    Khader, SA
    Pearl, J
    Gilmartin, L
    Jelly-Gibbs, DM
    Ghilardi, N
    de Sauvage, FJ
    Cooper, AM
    FASEB JOURNAL, 2004, 18 (04): : A90 - A90